Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-22-103720
Filing Date
2022-04-13
Accepted
2022-04-13 09:04:29
Documents
12

Document Format Files

Seq Description Document Type Size
1 DEFA14A d330254ddefa14a.htm DEFA14A 73671
2 GRAPHIC g330254g01t58.jpg GRAPHIC 19866
3 GRAPHIC g330254g0415075222909.jpg GRAPHIC 3857
4 GRAPHIC g330254g66n09.jpg GRAPHIC 9524
5 GRAPHIC g330254pc2.jpg GRAPHIC 12260
6 GRAPHIC g330254pc3.jpg GRAPHIC 53231
7 GRAPHIC g330254snap0003.jpg GRAPHIC 1396
8 GRAPHIC g330254snap0004.jpg GRAPHIC 2099
9 GRAPHIC g330254snap0005.jpg GRAPHIC 1760
10 GRAPHIC g330254snap0006.jpg GRAPHIC 1485
11 GRAPHIC g330254snap0008.jpg GRAPHIC 949
12 GRAPHIC g330254snap3.jpg GRAPHIC 1828
  Complete submission text file 0001193125-22-103720.txt   225376
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-16174 | Film No.: 22823783
SIC: 2834 Pharmaceutical Preparations